Tradestie Institutional Equity Comparison Engine

CELUW vs CELU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CELU Overall Edge

CELU Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Celularity Inc. Class A Common Stock (CELU) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CELUW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CELU at N/M Forward P/E and -254.0% operating margin (-5.3% YoY). In options structure, CELUW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CELUW N/M vs CELU N/M Fwd P/E
Growth & Margin Winner CELU
Op Margin N/A vs -254.0% ยท YoY N/A vs -5.3%
Momentum & Technical Winner CELU
1Y -95.2% vs -72.6% ยท 52W Pos 2% vs 2%
Options & Structure Winner CELU
UNCLASSIFIED (N/A IV) vs BREAKDOWN (50th %ile IV)
CELUW US Equity
CELUW
Institutional Equity
$0.00
+533.33% 1D
Market Cap N/A
1M Return -54.76%
1Y Return -95.25%
Forward P/E N/M
Unified AI Score
41.3 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 50.0
CELU NASDAQ
Celularity Inc. Class A Common Stock
Pharmaceutical Preparations
$0.46
-1.05% 1D
Market Cap $15.2M
1M Return -55.9%
1Y Return -72.6%
Forward P/E N/M
Unified AI Score
42.9 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 67.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CELUW -95.25% CELU -72.6% Spread: +38.97 pp (CELU Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CELUW TTM Op. Margin: N/A CELU TTM Op. Margin: -254.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CELUW vs CELU. Trailing 12-month operating profitability (CELUW N/A vs CELU -254.0%) and valuation multiples (CELUW N/M vs CELU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CELUW (0) vs CELU (7)
Institutional Metric CELUW CELU Criterion Row Winner
Market Capitalization Scale N/A $15.2M Larger Scale CELU
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -5.3% Higher Growth CELU
Operating Margin (TTM) Profitability N/A -254.0% Higher Margin CELU
Net Profit Margin Profitability N/A -245.7% Higher Margin CELU
Return on Equity (ROE) Capital Efficiency N/A -6367.2% Higher ROE CELU
52-Week Range Position Momentum 2% ($0โ€“$0) 2% ($0โ€“$3) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 2163% Vol 2.01ฮฒ ยท 135% Vol Lower Realized Risk CELU
Unified Institutional Score Composite Signal 41.3 / 100 (SELL) 42.9 / 100 (HOLD) Higher Composite CELU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CELUW vs CELU Buy Guide
CELUW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CELUW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CELU BREAKDOWN
60d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CELU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CELUW nor CELU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.